Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells

Mol Cell Endocrinol. 2015 Jan 5:399:228-34. doi: 10.1016/j.mce.2014.10.006. Epub 2014 Oct 12.

Abstract

Foxp3+ regulatory T cells (Tregs) in lymphocytes facilitate the thyroid tumor growth and invasion. Very limited information is available on Foxp3 expression in thyroid cancer cells and its function is totally unknown. This study demonstrated that Foxp3 expression was increased in thyroid cancer cells. Inhibition of Foxp3 decreased cell proliferation and migration, but increased apoptosis, suggesting a positive role of Foxp3 in cancer growth. Interestingly, Foxp3 inhibition enhanced PPARγ expression and activity. In addition, Foxp3 inhibition downregulated NF-κB subunit p65 and cyclin D1 but upregulated caspase-3 levels. These molecular changes are in line with Foxp3 shRNA-mediated alteration of cell functions. Collectively, our study demonstrates that thyroid cancer cells express a high level of functional Foxp3 and that the inhibition of the Foxp3 suppresses the proliferation and migration but promotes apoptosis, suggesting that targeting Foxp3 in thyroid cancer cells may offer a novel therapeutic option for thyroid cancer.

Keywords: Apoptosis; Foxp3; PPARγ; Thyroid cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cell Movement
  • Cell Proliferation
  • Cyclin D1 / metabolism
  • Forkhead Transcription Factors / biosynthesis*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Jurkat Cells
  • Neoplasm Proteins / metabolism*
  • PPAR gamma / metabolism
  • Thyroid Neoplasms / metabolism*
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / therapy
  • Transcription Factor RelA / metabolism

Substances

  • CCND1 protein, human
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Neoplasm Proteins
  • PPAR gamma
  • RELA protein, human
  • Transcription Factor RelA
  • Cyclin D1